The Latest Cardiac and Vascular News
CALGARY, Alberta, Jan. 11, 2018 (GLOBE NEWSWIRE) — Resverlogix Corporation (“Resverlogix” or the “Company”) (TSX:RVX) and the Resverlogix BETonMACE Clinical Steering Committee (CSC), represented by Professor Kausik Ray (Chair), are pleased to announce the FDA acceptance of the Company’s Phase 3 BETonMACE trial Protocol amendments. On behalf of all members of the BETonMACE CSC, […]
N.Y. Presbyterian/Columbia implant EluNIR stent Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent – by CardiovascularBusiness DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States […]
DUBLIN–(BUSINESS WIRE)–The “Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, Plaque Modification, Hemodynamic Flow Alteration, IVC Filters, Guidewires) – Global Forecast to 2022” report has been added to Research and Markets’ offering. The global peripheral vascular devices market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the 23rd Annual International AF Symposium being held in Orlando, FL, January 11- 13, 2018. The symposium’s agenda will include several sessions dedicated to exploring device-based options for Left Atrial Appendage (LAA) closure […]
NEW PROVIDENCE, N.J.–(BUSINESS WIRE)– The Christ Hospital, Lindner Research Center in Cincinnati, Ohio, enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical study, designed to further assess the safety and effectiveness of the Svelte Drug-Eluting Stent (DES) Integrated Delivery System (IDS) and Rapid Exchange (RX) platforms. The randomized, controlled […]
DURHAM, N.C., Jan. 9, 2018 /PRNewswire/ — Micell Technologies announced the recent online publication of five-year data from the DESSOLVE I and II trials. The report, “Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials” was peer […]
WASHINGTON, Jan. 8, 2018 /PRNewswire-USNewswire/ — In a new health policy statement, the American College of Cardiology identifies how to best support health care advances in three arenas—digital health, big data and precision health. Health care transformation is the product of a shared vision between a broad range of stakeholders to establish the […]
MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017. This represents growth of approximately 9.9 percent on a reported basis, approximately 8.1 percent on an operational basis (excludes the […]
MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — CardioFocus Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that it has entered into an expanded partnership with Japan Lifeline. The expanded partnership solidifies the commercial strategy for bringing the HeartLight® Endoscopic […]
WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast® Catheters have been successfully reprocessed by the company’s partner, Northeast Scientific, Inc. (NES), since NES received FDA clearance for reprocessing the popular vein ablation catheter in 2011. […]
